Skip to content
JournalsWorldThe Global Research Discovery Platform
Login Sign Up
SCHOLARLY PUBLICATION ✓ Open Access

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data

Ethan G Cerami, Jianjiong Gao, Uğur Doğrusöz, Benjamin E Gross, Selçuk Onur Sümer, Bülent Arman Aksoy, Anders Jacobsen, Caitlin J. Byrne, Michael Heuer, Erik Larsson, Yevgeniy Antipin, Boris A. Reva, Arthur P. Goldberg, Chris Sander, Nikolaus D. Schultz

📖 Cancer Discovery → 📅 2012-05-01 🔗 DOI: 10.1158/2159-8290.cd-12-0095
View Journal Profile → ⬇ Download PDF View Official Paper ↗

📄 Abstract

The cBio Cancer Genomics Portal (http://cbioportal.org) is an open-access resource for interactive exploration of multidimensional cancer genomics data sets, currently providing access to data from more than 5,000 tumor samples from 20 cancer studies. The cBio Cancer Genomics Portal significantly lowers the barriers between complex genomic data and cancer researchers who want rapid, intuitive, and high-quality access to molecular profiles and clinical attributes from large-scale cancer genomics projects and empowers researchers to translate these rich data sets into biologic insights and clinical applications.

📤 Share this page

Found this useful? Share it with your network.

𝕏XfFacebookinLinkedIn✆WhatsApp✈Telegram✉EmailMMendeley
✓ Link copied! Paste it on ResearchGate / Academia.edu

🔬 Related Research Papers

Cancer Discovery

Genome-Informed Targeted Therapy for Osteosarcoma

Leanne C. Sayles, Marcus R. Breese et al. 2018-09-28 · Read paper → Cancer Discovery

Serine Catabolism Regulates Mitochondrial Redox Control during Hypoxia

Jiangbin Ye, Jing Fan et al. 2014-09-04 · Read paper → Cancer Discovery

Tolerance of Whole-Genome Doubling Propagates Chromosomal Instability and Accelerates Cancer Genome Evolution

Sally M. Dewhurst, Nicholas McGranahan et al. 2014-01-16 · Read paper → Cancer Discovery

Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

Sarah J. Hill, Brennan James Decker et al. 2018-09-13 · Read paper → Cancer Discovery

A Diverse Array of Cancer-Associated MTOR Mutations Are Hyperactivating and Can Predict Rapamycin Sensitivity

Brian C. Grabiner, Valentina Nardi et al. 2014-03-14 · Read paper → Cancer Discovery

Oncogenic Isocitrate Dehydrogenase Mutations: Mechanisms, Models, and Clinical Opportunities

Rob A. Cairns, Tak W. Mak 2013-06-25 · Read paper → Cancer Discovery

Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy

Fernanda G. Herrera, Catherine Ronet et al. 2021-09-03 · Read paper → Cancer Discovery

BET Proteins as Targets for Anticancer Treatment

Anastasios Stathis, Francesco Bertoni 2017-12-20 · Read paper → Cancer Discovery

An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR–Dependent Pathway

Deliang Guo, Felicia Reinitz et al. 2011-09-16 · Read paper → Cancer Discovery

Cellular Plasticity in Cancer

Salina Yuan, Robert J. Norgard, Ben Z. Stanger 2019-04-16 · Read paper → Cancer Discovery

Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions

Christine Marie Lovly, Abha A. Gupta et al. 2014-05-29 · Read paper → Cancer Discovery

Mutant BRAF and MEK Inhibitors Regulate the Tumor Immune Microenvironment via Pyroptosis

Dan A. Erkes, Weijia Cai et al. 2019-12-03 · Read paper →